Literature DB >> 34876667

Omicron is bad but the global response is worse.

.   

Abstract

Entities:  

Keywords:  Intellectual-property rights; Policy; SARS-CoV-2; Vaccines

Mesh:

Substances:

Year:  2021        PMID: 34876667     DOI: 10.1038/d41586-021-03616-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Emergence of SARS-CoV-2 Variants in the World: How Could This Happen?

Authors:  Alfredo Parra-Lucares; Paula Segura; Verónica Rojas; Catalina Pumarino; Gustavo Saint-Pierre; Luis Toro
Journal:  Life (Basel)       Date:  2022-01-28

2.  COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods.

Authors:  Syed Mahfuz Al Hasan; Jennifer Saulam; Fumiaki Mikami; Kanae Kanda; Hideto Yokoi; Tomohiro Hirao
Journal:  J Infect Public Health       Date:  2022-05-24       Impact factor: 7.537

Review 3.  Past, Present and Future: The Relationship Between Circular RNA and Immunity.

Authors:  Junjie Gu; Chongying Su; Fei Huang; Yuwei Zhao; Jing Li
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 4.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 5.  COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.

Authors:  Harald Brüssow
Journal:  Microb Biotechnol       Date:  2022-04-20       Impact factor: 6.575

6.  Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: Current global scenario.

Authors:  Ranjan K Mohapatra; Ashish K Sarangi; Venkataramana Kandi; Mohammad Azam; Ruchi Tiwari; Kuldeep Dhama
Journal:  J Med Virol       Date:  2022-01-05       Impact factor: 20.693

7.  Reflections after 2 years of COVID-19 pandemic.

Authors:  Daniele Focosi; Arturo Casadevall; Fabrizio Maggi; Guido Antonelli
Journal:  Rev Med Virol       Date:  2022-04-05       Impact factor: 11.043

8.  The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis.

Authors:  Xinsheng Wu; Guohui Wu; Yanmin Ma; Xiaojie Huang; Yuecheng Yang; Yanshan Cai; Ganfeng Luo; Ping Ma; Ying Qiao; Yuanyi Chen; Yi-Fan Lin; Yanxiao Gao; Yuewei Zhan; Wei Song; Yingying Wang; Rugang Wang; Xuejuan Yang; Lijun Sun; Hongxia Wei; Quanmin Li; Xiaoli Xin; Lijing Wang; Xicheng Wang; Ronghui Xie; Lijuan Yang; Xiaojun Meng; Jin Zhao; Linghua Li; Tong Zhang; Junjie Xu; Gengfeng Fu; Huachun Zou
Journal:  Lancet Reg Health West Pac       Date:  2022-08-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.